Vertex Stock Future Price Prediction


USD 316.33  1.03  0.33%   

Vertex Pharmaceutic stock price prediction is an act of determining the future value of Vertex Pharmaceutic shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Vertex Pharmaceutic's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Vertex Pharmaceutic and does not consider all of the tangible or intangible factors available from Vertex Pharmaceutic's fundamental data. We analyze noise-free headlines and recent hype associated with Vertex Pharmaceutic, which may create opportunities for some arbitrage if properly timed.
Also, please take a look at Vertex Pharmaceutic Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Vertex Pharmaceutic based on different types of headlines from major news networks to social media. The Vertex stock price prediction module provides an analysis of price elasticity to changes in media outlook on Vertex Pharmaceutic over a specific investment horizon.
Quarterly Earnings Growth YOY
EPS Estimate Next Quarter
EPS Estimate Current Year
EPS Estimate Next Year
Wall Street Target Price
EPS Estimate Current Quarter
Using Vertex Pharmaceutic hype-based prediction, you can estimate the value of Vertex Pharmaceutic from the perspective of Vertex Pharmaceutic response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Vertex Pharmaceutic using Vertex Pharmaceutic's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Vertex using crowd psychology based on the activity and movement of Vertex Pharmaceutic's stock price.
Vertex Pharmaceutic Total Assets Per Share are fairly stable at the moment as compared to the past year. Vertex Pharmaceutic reported Total Assets Per Share of 52.78 in 2021. Debt to Equity Ratio is likely to rise to 0.05 in 2022, whereas Inventory Turnover is likely to drop 2.81 in 2022.

Vertex Pharmaceutic Short Interest

A significant increase or decrease in Vertex Pharmaceutic's short interest from the previous month could be a good indicator of investor sentiment towards Vertex. Short interest can provide insight into the potential direction of Vertex Pharmaceutic stock and how bullish or bearish investors feel about the market overall. An investor who is long Vertex Pharmaceutic may also wish to track short interest. As short interest increases, investors should be becoming more worried about Vertex Pharmaceutic and may potentially protect profits, hedge Vertex Pharmaceutic with its derivative instruments, or be ready for some potential downside.
200 Day MA
Short Percent
Short Ratio
Shares Short Prior Month
2.8 M
50 Day MA
Shares Short

Vertex Pharmaceutic Hype to Price Pattern

Investor biases related to Vertex Pharmaceutic's public news can be used to forecast risks associated with investment in Vertex. The trend in average sentiment can be used to explain how an investor holding Vertex can time the market purely based on public headlines and social activities around Vertex Pharmaceutic. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Vertex Pharmaceutic's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Vertex Pharmaceutic.

Vertex Pharmaceutic Implied Volatility

Vertex Pharmaceutic's implied volatility exposes the market's sentiment of Vertex Pharmaceutic stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Vertex Pharmaceutic's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Vertex Pharmaceutic stock will not fluctuate a lot when Vertex Pharmaceutic's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Vertex Pharmaceutic. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Vertex Pharmaceutic to buy its stock at a price that has no basis in reality. In that case, they are not buying Vertex because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Vertex Pharmaceutic after-hype prediction price

  $ 315.31  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Vertex contract

Based on the Rule 16, the options market is currently suggesting that Vertex Pharmaceutic will have an average daily up or down price movement of about 1.23% per day over the life of the 2022-12-02 option contract. With Vertex Pharmaceutic trading at $316.33, that is roughly $3.88. If you think that the market is fully incorporating Vertex Pharmaceutic's daily price movement you should consider acquiring Vertex Pharmaceutic options at the current volatility level of 19.64%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Vertex Pharmaceutic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Vertex Pharmaceutic in the context of predictive analytics.
LowReal ValueHigh
19 Analysts
LowTarget PriceHigh
Estimates (9)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Vertex Pharmaceutic. Your research has to be compared to or analyzed against Vertex Pharmaceutic's peers to derive any actionable benefits. When done correctly, Vertex Pharmaceutic's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Vertex Pharmaceutic.

Vertex Pharmaceutic After-Hype Price Prediction Density Analysis

As far as predicting the price of Vertex Pharmaceutic at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vertex Pharmaceutic or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Vertex Pharmaceutic, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Vertex Pharmaceutic Estimiated After-Hype Price Volatility

In the context of predicting Vertex Pharmaceutic's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vertex Pharmaceutic's historical news coverage. Vertex Pharmaceutic's after-hype downside and upside margins for the prediction period are 313.10 and 317.52, respectively. We have considered Vertex Pharmaceutic's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 316.33
After-hype Price
Vertex Pharmaceutic is very steady asset. Analysis and calculation of next after-hype price of Vertex Pharmaceutic is based on 3 months time horizon.

Vertex Pharmaceutic Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Vertex Pharmaceutic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vertex Pharmaceutic backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vertex Pharmaceutic, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.16  2.20   0.78    0.08  9 Events / Month5 Events / MonthIn about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Vertex Pharmaceutic Hype Timeline

Vertex Pharmaceutic is at this time traded for 316.33. The entity has historical hype elasticity of -0.78 and average elasticity to hype of competition of -0.08. Vertex is anticipated to decline in value after the next headline with the price expected to drop to 315.31. The average volatility of media hype impact on the company price is about 45.17%. The price decrease on the next newsis expected to be -0.32% whereas the daily expected return is at this time at 0.16%. The volatility of related hype on Vertex Pharmaceutic is about 453.09% with expected price after next announcement by competition of 316.25. About 95.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.31. Vertex Pharmaceutic recorded earning per share (EPS) of 12.87. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 24th of August 2000. Given the investment horizon of 90 days the next anticipated press release will be in about 9 days.
Also, please take a look at Vertex Pharmaceutic Basic Forecasting Models to cross-verify your projections.

Vertex Pharmaceutic Related Hype Analysis

Having access to credible news sources related to Vertex Pharmaceutic's direct competition is more important than ever and may enhance your ability to predict Vertex Pharmaceutic's future price movements. Getting to know how Vertex Pharmaceutic rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vertex Pharmaceutic may potentially react to the hype associated with one of its peers.
At Risk
ABBVAbbvie Inc 2.18 9 per month 1.49  0.11  2.89 (2.12)  8.93 
ABTAbbott Laboratories(0.81) 8 per month 1.72 (0.0072)  2.87 (2.23)  10.13 
ALKSAlkermes Plc 0.18 5 per month 0.00 (0.0483)  3.48 (2.88)  7.52 
AMGNAmgen Inc 4.27 8 per month 1.21  0.11  2.97 (1.56)  7.78 
BIIBBiogen Inc(3.51) 8 per month 1.27  0.12  3.32 (2.42)  44.31 
BIOBio-Rad Laboratories(5.85) 6 per month 0.00 (0.13)  3.91 (5.28)  13.43 
BMYBristol-Myers Squibb(0.85) 5 per month 1.46  0.07  2.63 (1.82)  7.44 
BSPMBiostar Pharmaceuticals 0.00 2 per month 0.00  0.00  0.00  0.00  0.00 
CPHIChina Pharma Holdings 0.02 6 per month 0.00 (0.1)  10.00 (8.33)  33.57 

Vertex Pharmaceutic Additional Predictive Modules

Most predictive techniques to examine Vertex price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vertex using various technical indicators. When you analyze Vertex charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Vertex Pharmaceutic Predictive Indicators

The successful prediction of Vertex Pharmaceutic stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Vertex Pharmaceutic, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Vertex Pharmaceutic based on analysis of Vertex Pharmaceutic hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Vertex Pharmaceutic's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vertex Pharmaceutic's related companies.
 2019 2021 2022 (projected)
Long Term Debt to Equity0.08850.05050.0518
Interest Coverage79.5449.1553.03

Story Coverage note for Vertex Pharmaceutic

The number of cover stories for Vertex Pharmaceutic depends on current market conditions and Vertex Pharmaceutic's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vertex Pharmaceutic is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vertex Pharmaceutic's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Vertex Pharmaceutic Short Properties

Vertex Pharmaceutic's future price predictability will typically decrease when Vertex Pharmaceutic's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vertex Pharmaceutic often depends not only on the future outlook of the potential Vertex Pharmaceutic's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vertex Pharmaceutic's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out1.10%
Short Percent Of Float1.11%
Float Shares256.1M
Average Daily Volume Last 10 Day1.37M
Shares Short Prior Month3.11M
Average Daily Volume In Three Month1.39M
Date Short Interest31st of October 2022
Also, please take a look at Vertex Pharmaceutic Basic Forecasting Models to cross-verify your projections. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for analysis

When running Vertex Pharmaceutic price analysis, check to measure Vertex Pharmaceutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceutic is operating at the current time. Most of Vertex Pharmaceutic's value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceutic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vertex Pharmaceutic's price. Additionally, you may evaluate how the addition of Vertex Pharmaceutic to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Is Vertex Pharmaceutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceutic. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
80.9 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Vertex Pharmaceutic is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceutic's value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceutic's market value can be influenced by many factors that don't directly affect Vertex Pharmaceutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceutic's value and its price as these two are different measures arrived at by different means. Investors typically determine Vertex Pharmaceutic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.